Welcoming you for any type of article submission for the upcoming issue on/before February 26, 2021.


Research Article
Volume 6 Issue 2 - 2021
Impact of a Cinnamon Extract Vs. Placebo on Metabolic Control in Patients with Type 2 Diabetes Mellitus
Pfützner A1,2*, Drexel H3,4, Grafinger P5, Hoppichler F6, Ludvik B7, Prager R8, Wascher TC9, Schnell O10 and Weitgasser R11,12
1Pfützner Science and Health Institute, Mainz, Germany
2Institute for Internal Medicine and Laboratory Medicine, University for Digital Technologies in Medicine and Dentistry, Wiltz, Luxembourg
3VIVIT Institute, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
4Private University of the Principality of Liechtenstein, Triesen, Liechtenstein
5Department of Internal Medicine 2, Kepler University Hospital, Linz, Austria
6Department of Internal Medicine, Barmherzige Brüder Hospital, Salzburg, Austria
7Department of Internal Medicine 1, Rudolfstiftung Hospital, Vienna, Austria
8Karl Landsteiner Institute for Metabolism and Nephrology, Vienna, Austria
9Department of Internal Medicine 1, Hanusch Hospital, Vienna, Austria
10Institute for Diabetes Research, Munich, Germany
11Department of Internal Medicine/Diabetology, Wehrle-Diakonissen Hospital, Salzburg, Austria
12Department of Internal Medicine 1, University Hospital Salzburg, Salzburg, Austria
*Corresponding Author: Pfützner A, Pfützner Science and Health Institute, Mainz, Germany and Institute for Internal Medicine and Laboratory Medicine, University for Digital Technologies in Medicine and Dentistry, Wiltz, Luxembourg.
Received: December 21, 2021; Published: January 30, 2021




Abstract

Background: Cinnamon preparations have been shown to reduce blood glucose and improve HbA1c in patients with Type 2 Diabetes mellitus. However, some meta-analyses have resulted in inconclusive data due to the heterogeneity of materials and patients in various published trials. In order to evaluate the effects of a cinnamon extract preparation on metabolic control, we performed a double-blind randomized placebo-controlled prospective study with a cinnamon extract from Cinnamomum aromaticum (C. cassia).

Subjects/Methods: We included 109 patients with type 2 diabetes and suboptimal glycemic control (HbA1 ≥ 7.0). Patients were randomized to receive one capsule daily containing 314 mg of cinnamon extract or placebo for four months on top of their regular treatment. Observation parameters were changes in HbA1c, HOMA-IR, hsCRP, adiponectin and lipids.

Results: HbA1c improved from 7.92 ± 0.98% to 7.39 ± 0.98% in the cinnamon group (-7%, p < 0.005) and from 7.73 ± 0.80% to 7.44 ± 0.94% in the placebo group (-3.8%; p < 0.05). Significant differences in favour of the cinnamon intervention were seen for almost all indicators of insulin resistance, inflammation and lipid distribution. Both treatments were well tolerated.

Conclusion: We found a consistent improvement in markers of glycaemic control, chronic systemic inflammation and insulin resistance during supplementation with cinnamon extract in comparison to further deteriorations with placebo. These results support the use of cinnamon extracts as dietary supplement for patients with type 2 diabetes and metabolic syndrome.

Keywords: Cinnamomum; Cinnamon; Type 2 Diabetes and Metabolic Syndrome

References

  1. Anderson RA., et al. “Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity”. Journal of Agricultural and Food Chemistry 52 (2004): 65-70.
  2. Jarvill-Taylor KJ., et al. “A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes”. The Journal of the American College of Nutrition 20 (2001): 327-336.
  3. Imparl-Radosevich J., et al. “Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling”. Hormone Research 50 (1998): 177-182.
  4. Qin B., et al. “Cinnamon extract prevents the insulin resistance induced by a high-fructose diet”. Hormone and Metabolic Research 36 (2004): 119-125.
  5. Qin B., et al. “Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes”. Journal of Diabetes Science and Technology 4 (2010): 685-693.
  6. Forst T., et al. “Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes”. Journal of Diabetic Complications 19 (2005): 128-132.
  7. Khan A., et al. “Insulin potentiating factor and chromium content of selected foods and spices”. Biological Trace Element Research 24 (1990): 183-188.
  8. Broadhurst CL., et al. “Insulin-like biological activity of culinary and medicinal plant aqueous extracts In vitro”. Journal of Agricultural and Food Chemistry 48 (2000): 849-852.
  9. Kreydiyyeh SI., et al. “Effect of cinnamon, clove and some of their constituents on the Na(+)-K(+)-ATPase activity and alanine absorption in the rat jejunum”. Food and Chemical Toxicology 38 (2000): 755-762.
  10. Kim SH., et al. “Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice”. Journal of Ethnopharmacology 104 (2006): 119-123.
  11. Namazi N., et al. “The impact of cinnamon on anthropometric indices and glycemic status in patients with type 2 diabetes: A systematic review and meta-analysis of clinical trials”. Complementary Therapies in Medicine 43 (2019): 92-101.
  12. Deyno S., et al. “Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression”. Diabetes Research and Clinical Practice 156 (2019): 107815.
  13. Santos HO and Da Silva GAR. “To what extent does cinnamon administration improve the glycemic and lipid profiles?” Clinical Nutrition ESPEN 27 (2018): 1-9.
  14. Allen RW., et al. “Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis”. Annals of Family Medicine5 (2013): 452-459.
  15. Leach MJ and Kumar S. “Cinnamon for diabetes mellitus”. Cochrane Database of Systematic Reviews 9 (2012): CD007170.
  16. Altschuler JA., et al. “The effect of cinnamon on A1C among adolescents with type 1 diabetes”. Diabetes Care 30 (2007): 813-816.
  17. Khan A., et al. “Cinnamon improves glucose and lipids of people with type 2 diabetes”. Diabetes Care 26 (2003): 3215-3218.
  18. Khan R., et al. “Cinnamon may reduce glucose, lipid and cholesterol level in type 2 diabetic individuals”. Pakistan Journal of Nutrition 9 (2010): 430-433.
  19. Rosado JM. “A study to determine the effects of cinnamon on blood glucose and lipid levels in persons with type-2 diabetes”. Honolulu: University of Hawaii (2010).
  20. Vanschoonbeek K., et al. “Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients”. Journal of Nutrition 136 (2006): 977-980.
  21. Mang B., et al. “Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2”. European Journal of Clinical Investigation 36 (2006): 340-344.
  22. Blevins SM., et al. “Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes”. Diabetes Care 30 (2007): 2236-2237.
  23. American Diabetes Association 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020”. Diabetes Care1 (2020): S66-S76.
  24. Akilen R., et al. “Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial”. Diabetes Medicine 27 (2010): 1159-1167.
  25. Crawford P. “Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial”. Journal of the American Board of Family Medicine 22 (2009): 507-512.
  26. Suppapitiporn S., et al. “The effect of cinnamon cassia powder in type 2 diabetes mellitus”. Journal of the Medical Association of Thailand 3 (2006): S200-S205.
  27. Matthews DR., et al. “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man”. Diabetologia 28 (1985): 412-419.
  28. Pfützner A., et al. “Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes”. Diabetes Care 27 (2004): 682-687.
  29. Hedblad B., et al. “Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden”. Diabetes Medicine 17 (2000): 299-307.
  30. Pfützner A., et al. “Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride”. Metabolism 55 (2006): 20-25.
  31. Pfützner A., et al. “Pioneer study: PPARgamma activation results in overall improvement of clinical and metabolic markers associated with insulin resistance independent of long-term glucose control”. Hormone and Metabolic Research 37 (2005): 510-515.
  32. Hlebowicz J., et al. “Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects”. The American Journal of Clinical Nutrition 85 (2007): 1552-1556.
  33. Hlebowicz J., et al. “Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects”. The American Journal of Clinical Nutrition 89 (2009): 815-821.
  34. Qureshi AS., et al. “Effect of ethanolic preparations of cinnamon (Cinnamomum zeylanicum) extract on hematologic and histometric parameters of selected organs in Alloxan® induced diabetic female albino rats”. Journal of Diabetes and Metabolic Disorders 18 (2019): 505-512.
  35. Romeo GR., et al. “Influence of Cinnamon on Glycemic Control in Individuals With Prediabetes: A Randomized Controlled Trial”. Journal of the Endocrine Society 13 (2020): bvaa094.
Citation: Pfützner A., et al. “Impact of a Cinnamon Extract Vs. Placebo on Metabolic Control in Patients with Type 2 Diabetes Mellitus”. EC Endocrinology and Metabolic Research 6.2 (2021): 32-42.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk